Sylvia Hoeks

Sylvia Hoeks

Highest Rated: 88% Blade Runner 2049 (2017)

Lowest Rated: 11% Renegades (2017)

Birthday: Jun 01, 1983

Birthplace: Maarheeze, Noord-Brabant, The Netherlands

Born in the Netherlands in 1983, Sylvia Hoeks was a professional model, travelling throughout Europe during her teenage years. When she returned, Hoeks enrolled in the Maastricht Theater Academy. After graduation, she appeared in a number of Dutch TV series and films, first gaining acclaim for her supporting role in the film "Duska" (2007), which earned her the Dutch equivalent of a Best Supporting Actress Oscar. She continued to work in Dutch and European cinema, finally breaking through to the English-language market in 2016, when she had a recurring role on the series "Berlin Station" (Epix, 2016-). The next year was Hoeks' breakthrough internationally, when she played the replicant Luv in the high-profile film "Blade Runner 2049" (2017).

Photos

Highest rated movies

Filmography

Movies

Credit
23% 23% All the Devil's Men Leight (Character) - 2018
No Score Yet No Score Yet Elite squad Unknown (Character) - 2018
39% 36% The Girl in the Spider's Web Camilla Salander (Character) $14.8M 2018
88% 81% Blade Runner 2049 Luv (Character) $91.5M 2017
11% 41% Renegades Lara Simic (Character) - 2017
No Score Yet 56% Bro's Before Ho's Anna (Character) - 2013
56% 77% The Best Offer Claire (Character) $82K 2013
31% 57% The Girl and Death Elise (Character) - 2012
No Score Yet 46% The Gangs of OSS (De Bende van Oss) Unknown (Character) - 2011
No Score Yet No Score Yet The Gang of Oss Johanna van Heesch (Character) - 2011
No Score Yet 35% Tirza Tirza (Character) - 2010
No Score Yet 50% The Storm Julia (Character) - 2009
No Score Yet No Score Yet Tiramisu Vanessa (Character) - 2008
20% 56% Duska (Dushka) Unknown (Character) - 2007

TV

Credit
43% 85% See Queen Kane (Character) 2019
No Score Yet No Score Yet Harry Guest 2017
No Score Yet No Score Yet Overspel Iris Hoegaarde (Character) 2013 2011

QUOTES FROM Sylvia Hoeks CHARACTERS

No quotes approved yet.